EE200300585A - PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks - Google Patents
PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviksInfo
- Publication number
- EE200300585A EE200300585A EEP200300585A EEP200300585A EE200300585A EE 200300585 A EE200300585 A EE 200300585A EE P200300585 A EEP200300585 A EE P200300585A EE P200300585 A EEP200300585 A EE P200300585A EE 200300585 A EE200300585 A EE 200300585A
- Authority
- EE
- Estonia
- Prior art keywords
- treatment
- combination
- pde4 inhibitor
- anticholinergic agent
- obstructive airways
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 208000027771 Obstructive airways disease Diseases 0.000 title 1
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 title 1
- 239000000812 cholinergic antagonist Substances 0.000 title 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29360601P | 2001-05-25 | 2001-05-25 | |
| GB0129396A GB0129396D0 (en) | 2001-12-07 | 2001-12-07 | Pharmaceutical combination |
| GB0210240A GB0210240D0 (en) | 2002-05-03 | 2002-05-03 | Pharmaceutical combination |
| PCT/EP2002/005726 WO2002096463A1 (en) | 2001-05-25 | 2002-05-24 | A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200300585A true EE200300585A (et) | 2004-04-15 |
Family
ID=27256347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300585A EE200300585A (et) | 2001-05-25 | 2002-05-24 | PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20040147544A1 (et) |
| EP (1) | EP1395288A1 (et) |
| JP (1) | JP2005508861A (et) |
| KR (1) | KR20040007605A (et) |
| CN (1) | CN1511042A (et) |
| AP (1) | AP2003002909A0 (et) |
| BG (1) | BG108382A (et) |
| BR (1) | BR0209992A (et) |
| CA (1) | CA2446613A1 (et) |
| CO (1) | CO5640041A2 (et) |
| CR (1) | CR7152A (et) |
| CZ (1) | CZ20033150A3 (et) |
| EE (1) | EE200300585A (et) |
| HU (1) | HUP0400037A2 (et) |
| IL (1) | IL158776A0 (et) |
| MA (1) | MA27027A1 (et) |
| MX (1) | MXPA03010162A (et) |
| NO (1) | NO20035204D0 (et) |
| NZ (1) | NZ529335A (et) |
| OA (1) | OA12610A (et) |
| PA (1) | PA8546001A1 (et) |
| PL (1) | PL367085A1 (et) |
| SK (1) | SK14312003A3 (et) |
| TN (1) | TNSN03123A1 (et) |
| WO (1) | WO2002096463A1 (et) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US20040058950A1 (en) * | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| DE10230769A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren |
| PT1610787E (pt) * | 2003-03-28 | 2008-04-23 | Nycomed Gmbh | Associação sinérgica compreendendo roflumilast e um agente anticolinérgico seleccionado de sais de tiotrópio para o tratamento de doenças respiratórias |
| MXPA05010161A (es) * | 2003-03-28 | 2005-11-16 | Altana Pharma Ag | Combinacion sinergistica que comprende roflumilast y un agente anticolinergico seleccionado a partir de sales de ipratropio, oxitropio y tiotropio para el tratamiento de enfermedades respiratorias. |
| CA2550848C (en) * | 2004-02-06 | 2013-02-26 | Meda Pharma Gmbh & Co. Kg | Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| RU2006132043A (ru) * | 2004-02-06 | 2008-03-20 | МЕДА Фарма ГмбХ унд Ко.КГ (DE) | Комбинация и фармацевтический препарат для лечения ринита |
| SI1713473T1 (sl) | 2004-02-06 | 2013-06-28 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB |
| WO2005102344A1 (ja) * | 2004-04-27 | 2005-11-03 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
| SI1634595T1 (sl) * | 2004-08-19 | 2008-12-31 | Rottapharm Spa | N-fenilbenzamidni derivati kot zdravila za zdravljenje kronične obstruktivne pljučne bolezni (KOPB) |
| SI1863476T1 (sl) | 2005-03-16 | 2016-05-31 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni |
| GB0511066D0 (en) * | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| KR100696432B1 (ko) * | 2005-08-31 | 2007-03-19 | 김용환 | 건강진단용 팬티 |
| EP1948167A1 (en) * | 2005-10-19 | 2008-07-30 | Ranbaxy Laboratories, Ltd. | Compositions of phosphodiesterase type iv inhibitors |
| EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| SI1971369T1 (sl) | 2005-12-21 | 2009-12-31 | Meda Pharma Gmbh & Co Kg | Kombinacija R,R-glikopirolata,roliprama in budezonida za zdravljenje vnetnih bolezni |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552407A (en) * | 1993-06-11 | 1996-09-03 | New York University Medical Center | Anhydroecgonine compounds and their use as anticholinergic agents |
| DK0837860T3 (da) * | 1995-06-06 | 2002-05-27 | Pfizer | Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner |
| US20020193393A1 (en) * | 2001-03-07 | 2002-12-19 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
-
2002
- 2002-05-24 BR BR0209992-6A patent/BR0209992A/pt not_active IP Right Cessation
- 2002-05-24 PA PA20028546001A patent/PA8546001A1/es unknown
- 2002-05-24 OA OA1200300304A patent/OA12610A/en unknown
- 2002-05-24 HU HU0400037A patent/HUP0400037A2/hu unknown
- 2002-05-24 AP APAP/P/2003/002909A patent/AP2003002909A0/en unknown
- 2002-05-24 IL IL15877602A patent/IL158776A0/xx unknown
- 2002-05-24 NZ NZ529335A patent/NZ529335A/en unknown
- 2002-05-24 KR KR10-2003-7015352A patent/KR20040007605A/ko not_active Application Discontinuation
- 2002-05-24 PL PL02367085A patent/PL367085A1/xx not_active Application Discontinuation
- 2002-05-24 JP JP2002592972A patent/JP2005508861A/ja not_active Withdrawn
- 2002-05-24 CZ CZ20033150A patent/CZ20033150A3/cs unknown
- 2002-05-24 EP EP02750977A patent/EP1395288A1/en not_active Withdrawn
- 2002-05-24 CA CA002446613A patent/CA2446613A1/en not_active Abandoned
- 2002-05-24 SK SK1431-2003A patent/SK14312003A3/sk not_active Application Discontinuation
- 2002-05-24 MX MXPA03010162A patent/MXPA03010162A/es unknown
- 2002-05-24 EE EEP200300585A patent/EE200300585A/et unknown
- 2002-05-24 US US10/478,755 patent/US20040147544A1/en not_active Abandoned
- 2002-05-24 CN CNA028104986A patent/CN1511042A/zh active Pending
- 2002-05-24 WO PCT/EP2002/005726 patent/WO2002096463A1/en not_active Application Discontinuation
-
2003
- 2003-07-08 TN TNPCT/EP2002/005726A patent/TNSN03123A1/en unknown
- 2003-11-19 CO CO03102140A patent/CO5640041A2/es not_active Application Discontinuation
- 2003-11-19 CR CR7152A patent/CR7152A/es not_active Application Discontinuation
- 2003-11-20 MA MA27408A patent/MA27027A1/fr unknown
- 2003-11-24 BG BG108382A patent/BG108382A/bg unknown
- 2003-11-24 NO NO20035204A patent/NO20035204D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA27027A1 (fr) | 2004-12-20 |
| HUP0400037A2 (hu) | 2004-04-28 |
| US20040147544A1 (en) | 2004-07-29 |
| CN1511042A (zh) | 2004-07-07 |
| AP2003002909A0 (en) | 2003-12-31 |
| EP1395288A1 (en) | 2004-03-10 |
| CZ20033150A3 (cs) | 2004-06-16 |
| NO20035204D0 (no) | 2003-11-24 |
| CO5640041A2 (es) | 2006-05-31 |
| WO2002096463A1 (en) | 2002-12-05 |
| BG108382A (bg) | 2004-12-30 |
| CR7152A (es) | 2004-02-23 |
| JP2005508861A (ja) | 2005-04-07 |
| BR0209992A (pt) | 2004-04-06 |
| MXPA03010162A (es) | 2004-03-10 |
| TNSN03123A1 (en) | 2005-12-23 |
| NZ529335A (en) | 2005-09-30 |
| IL158776A0 (en) | 2004-05-12 |
| PA8546001A1 (es) | 2003-12-30 |
| PL367085A1 (en) | 2005-02-21 |
| SK14312003A3 (sk) | 2004-08-03 |
| KR20040007605A (ko) | 2004-01-24 |
| OA12610A (en) | 2006-06-09 |
| CA2446613A1 (en) | 2002-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200300585A (et) | PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks | |
| CY2022009I1 (el) | Διυδροναφθυριδινες και σχετικες ενωσεις χρησιμες ως αναστολεις κινασης για τη θεραπεια πολλαπλασιαστικων ασθενειων | |
| EE200300586A (et) | Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks | |
| PL362477A1 (en) | Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases | |
| CY2013039I1 (el) | Φθοροϋποκατεστημενη ωμεγα-καρβοξυαρυλ διφαινυλ ουρια για τη θεραπεια και προληψη ασθενειων και καταστασεων | |
| CY2014019I2 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
| NO20033594D0 (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
| IL160065A0 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| NO20044402L (no) | Kombinasjonsbehandling av kemokine-medierte sykdommer | |
| WO2003011274A3 (en) | Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma | |
| PT1392292E (pt) | Piranoindazoles e sua utilizacao para o tratamento de glaucoma | |
| NO20041272L (no) | Tetracycline derivatives and methods of use thereof | |
| NO20041833L (no) | Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet | |
| SI1627639T1 (sl) | Uporaba inhibitorjev COX-2 za zdravljenje afektivnih motenj | |
| NO20026008D0 (no) | Fremgangsmåte for behandling av cardiovaskul¶re sykdommer | |
| PT1411926E (pt) | Inibidores de integrina para o tratamento de doencas oftalmicas | |
| NO20043370L (no) | N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer | |
| IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| IL159379A0 (en) | Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases | |
| EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
| NO20033801D0 (no) | Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser | |
| PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
| AU2002366028A1 (en) | Use of fk506 and analogues for treating allergic diseases | |
| EP1455780A4 (en) | NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA | |
| NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon |